UNITED
STATES |
Washington, D.C. 20549 |
|
SCHEDULE
13D |
OAKLEY, INC.
(Name of Issuer)
Common Stock, $0.01 par value per share
(Title of Class of Securities)
673662102
(CUSIP Number)
Michael
A. Boxer, Esq.
Senior Vice President & General Counsel
Luxottica U.S. Holdings Corp.
44 Harbor Park Drive
Port Washington, New York 11050
(516) 484-3800
with
a copy to:
Jonathan Goldstein, Esq.
David A. Sakowitz, Esq.
Winston & Strawn LLP
200 Park Avenue
New York, New York 10166
(212) 294-6700
(Name, Address and
Telephone Number of Person
Authorized to Receive Notices and Communications)
June 20, 2007
(Date of Event which
Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
(1) The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 673662 10 2 |
|||||
|
|||||
|
1. |
Names of Reporting Persons. |
|||
|
|||||
|
2. |
Check the Appropriate Box if a Member of a Group (See Instructions) |
|||
|
|
(a) |
o |
||
|
|
(b) |
x |
||
|
|||||
|
3. |
SEC Use Only |
|||
|
|||||
|
4. |
Source of Funds (See
Instructions) |
|||
|
|||||
|
5. |
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o |
|||
|
|||||
|
6. |
Citizenship or Place of Organization |
|||
|
|||||
Number of |
7. |
Sole Voting Power |
|||
|
|||||
8. |
Shared Voting Power
|
||||
|
|||||
9. |
Sole Dispositive Power
|
||||
|
|||||
10. |
Shared Dispositive Power |
||||
|
|||||
|
11. |
Aggregate Amount
Beneficially Owned by Each Reporting Person |
|||
|
|||||
|
12. |
Check if the Aggregate
Amount in Row (11) Excludes Certain Shares (See Instructions) o |
|||
|
|||||
|
13. |
Percent of Class
Represented by Amount in Row (11) |
|||
|
|||||
|
14. |
Type of Reporting Person
(See Instructions) |
|||
*SEE INSTRUCTIONS BEFORE FILLING OUT!
(1) The Reporting Persons may be deemed to have acquired beneficial ownership of these shares pursuant to agreements with Mr. Jim Jannard, Oakley, Inc.s majority shareholder (the Shareholder). This figure includes 119,315 shares that the Shareholder has the right to acquire pursuant to vested options. See Items 3 - 6 of this Schedule 13D for information concerning the agreements with respect to the voting and disposition of these shares.
1
CUSIP No. 673662 10 2 |
|||||
|
|||||
|
1. |
Names of Reporting Persons. |
|||
|
|||||
|
2. |
Check the Appropriate Box if a Member of a Group (See Instructions) |
|||
|
|
(a) |
o |
||
|
|
(b) |
x |
||
|
|||||
|
3. |
SEC Use Only |
|||
|
|||||
|
4. |
Source of Funds (See Instructions) |
|||
|
|||||
|
5. |
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o |
|||
|
|||||
|
6. |
Citizenship or Place of Organization |
|||
|
|||||
Number of |
7. |
Sole Voting Power |
|||
|
|||||
8. |
Shared Voting Power
|
||||
|
|||||
9. |
Sole Dispositive Power
|
||||
|
|||||
10. |
Shared Dispositive Power |
||||
|
|||||
|
11. |
Aggregate Amount
Beneficially Owned by Each Reporting Person |
|||
|
|||||
|
12. |
Check if the Aggregate
Amount in Row (11) Excludes Certain Shares (See Instructions) o |
|||
|
|||||
|
13. |
Percent of Class
Represented by Amount in Row (11) |
|||
|
|||||
|
14. |
Type of Reporting Person
(See Instructions) |
|||
*SEE INSTRUCTIONS BEFORE FILLING OUT!
(1) The Reporting Persons may be deemed to have acquired beneficial ownership of these shares pursuant to agreements with the Shareholder. This figure includes 119,315 shares that the Shareholder has the right to acquire pursuant to vested options. See Items 3 - 6 of this Schedule 13D for information concerning the agreements with respect to the voting and disposition of these shares.
2
Item 1. Security and Issuer.
This Statement on Schedule 13D (the Schedule 13D) relates to shares of the common stock, $0.01 par value per share (Shares), of Oakley, Inc., a Washington corporation (the Company). The principal executive offices of the Company are located at One Icon, Foothill Ranch, California 92610.
Item 2. Identity and Background.
(a) This Schedule 13D is being filed jointly by Luxottica Group S.p.A., a company organized under the laws of the Republic of Italy (Luxottica), and Norma Acquisition Corp., a Washington corporation and a wholly owned subsidiary of Luxottica (NAC and, together with Luxottica, the Reporting Persons).
(b) Luxotticas principal business address is:
Luxottica Group S.p.A.
Via C. Cantù 2
20123 Milan
Italy
NACs registered address is:
Norma Acquisition Corp.
c/o Corporation Service Company
6500 Harbour Heights Pkwy, Suite 400
Mukilteo, Washington 98275
(c) Luxottica, together with its consolidated subsidiaries, is a leader in the eyewear industry, with a global retail and wholesale sales network and a portfolio of owned and licensed eyewear brands.
(d) Not applicable
(e) Not applicable
Item 3. Source and Amount of Funds or Other Consideration.
Please see the disclosure in Items 4 and 5 of this Schedule 13D for information regarding the consideration for the Shares that the Reporting Persons may be deemed to have beneficially acquired.
Item 4. Purpose of the Transaction.
On June 20, 2007, the Company entered into an Agreement and Plan of Merger (the Merger Agreement) with Luxottica and NAC, a wholly owned subsidiary of Luxottica formed for the purpose of effecting the transactions contemplated by the Merger Agreement, pursuant to which Luxottica will acquire all of the outstanding equity interests of the Company. Pursuant to the Merger Agreement, NAC will be merged (the Merger) with and into the Company with the Company surviving as a wholly owned indirect subsidiary of Luxottica. Each outstanding share of the Companys common stock will be converted into the right to receive U.S. $29.30 per share in cash without interest, and each outstanding option will be converted into the right to receive U.S. $29.30 per share in cash less the applicable option exercise price of such option for each share of common stock underlying such option. The total purchase price will be approximately U.S. $2.1 billion to be funded from operating cash flow, available lines of credit, and credit facilities to be available at the closing. The transaction is expected to close in the second half of
3
2007. The acquisition is subject to the approval of the Companys shareholders and the satisfaction of other customary conditions, including various governmental approvals.
This summary of the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the copy of the Merger Agreement which is filed as Exhibit 1 hereto and is incorporated herein by this reference.
Item 5. Interest in Securities of the Issuer.
(a) The Reporting Persons may be deemed to share beneficial ownership of 44,545,715 Shares, or approximately 64.2% of the Shares outstanding. This amount includes 119,315 Shares that the Shareholder has the right to acquire pursuant to vested options and of which the Reporting Persons may be deemed to share beneficial ownership. The Reporting Persons may be deemed to have acquired beneficial ownership of these Shares pursuant to the Voting Agreement, as defined and described in Item 5(c) below.
(b) Each of the Reporting Persons may be deemed to have shared voting and dispositive power over 44,545,715 Shares pursuant to the Voting Agreement.
(c) As an inducement to Luxottica to enter into the Merger Agreement described in Item 4 of this Schedule 13D, the Shareholder simultaneously entered into a voting agreement with Luxottica and NAC (the Voting Agreement) pursuant to which, among other things, he agreed: (1) to vote all of the Shares owned by him at any annual, special or other meeting of the shareholders of the Company, and at any adjournment or adjournments or postponements thereof, or pursuant to any consent in lieu of a meeting or otherwise (A) in favor of the Merger and the approval and adoption of the Merger Agreement and (B) except for all such actions that the Company or its board of directors is permitted to take under the Merger Agreement, against (i) an Acquisition Proposal (as defined in the Merger Agreement), other than the Merger, (ii) any action or agreement (including, without limitation, any amendment of any agreement) that would result in any condition to the consummation of the Merger set forth in the Merger Agreement not being capable of being fulfilled, (iii) any action that would result in a change in those persons constituting a majority of the board of directors of the Company, other than in connection with an annual meeting of the shareholders of the Company with respect to the slate of directors proposed by the incumbent board of directors of the Company (in which case he has agreed to vote for the slate proposed by the incumbent board) or (iv) any action that would materially impede, interfere with, delay, postpone or adversely affect in any material respect the Merger and the transactions contemplated by the Merger Agreement; (2) to keep all of the Shares owned by him free and clear of all liens, security interests, proxies, voting trusts or agreements, understandings or arrangements or any other encumbrances that would limit his ability to perform his obligations under the Voting Agreement; (3) except as otherwise contemplated by the Merger Agreement or the Voting Agreement, not to (A) offer for sale, sell, transfer, tender, pledge, encumber, assign or otherwise dispose of such Shares (including effecting short sales or certain derivative transactions) or enter into a contract to do any of the foregoing (except for transfers to family members or affiliates in certain circumstances), (B) grant any proxies or powers of attorney, or deposit such Shares into a voting trust or enter into a voting agreement with respect to such Shares or (C) enter into any agreement or arrangement providing for any such actions; and (4) not to exercise any dissenters rights in respect of such Shares that may arise with respect to the Merger. The Shareholder also agreed to refrain from certain soliciting activities with respect to competing acquisition proposals. The Shareholder has granted to NAC an irrevocable proxy to act for him solely with respect to the matters set forth in (1) above.
4
Exhibit |
|
Description |
Exhibit 1 |
|
Agreement and Plan of Merger by and among Luxottica Group S.p.A., Norma Acquisition Corp. and Oakley, Inc., dated as of June 20, 2007 (incorporated herein by reference from Exhibit 4.1 to the Current Report on Form 6-K filed by Luxottica on June 25, 2007) |
|
|
|
Exhibit 2 |
|
Voting Agreement by and among Luxottica Group S.p.A., Norma Acquisition Corp. and Jim Jannard, dated June 20, 2007 (incorporated by reference from Exhibit 15.1 to the Current Report on Form 6-K filed by Luxottica on June 25, 2007) |
5
SIGNATURES
After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
Dated: June 29, 2007
LUXOTTICA GROUP S.p.A. |
||
|
|
|
|
|
|
|
By: |
/s/ Enrico Cavatorta |
|
Name: Enrico Cavatorta |
|
|
Title: Chief Financial Officer |
|
|
|
|
|
|
|
|
NORMA ACQUISITION CORP. |
|
|
|
|
|
|
|
|
By: |
/s/ Enrico Cavatorta |
|
Name: Enrico Cavatorta |
|
|
Title: President |
6
EXHIBITS
Exhibit |
|
|
|
Description |
|
|
Exhibit 1 |
|
Agreement and Plan of Merger by and among Luxottica Group S.p.A., Norma Acquisition Corp. and Oakley, Inc., dated as of June 20, 2007 (incorporated herein by reference from Exhibit 4.1 to the Current Report on Form 6-K filed by Luxottica on June 25, 2007) |
||||
|
|
|
||||
Exhibit 2 |
|
Voting Agreement by and among Luxottica Group S.p.A., Norma Acquisition Corp. and Jim Jannard, dated June 20, 2007 (incorporated herein by reference from Exhibit 15.1 to the Current Report on Form 6-K filed by Luxottica on June 25, 2007) |
7